Literature DB >> 8999905

Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B-chain of the insulin molecule.

D C Mynarcik1, P F Williams, L Schaffer, G Q Yu, J Whittaker.   

Abstract

Recent studies utilizing alanine scanning mutagenesis have identified a major ligand binding domain of the secreted recombinant insulin receptor composed of two subdomains, one between amino acids 1 and 120 and the other between amino acids 704 and 716. In order to obtain a more detailed characterization of these subdomains, we examined the binding of an insulin superanalog, des-(B25-30)-[His-A8, Asp-B10, Tyr-B25 alpha-carboxamide]insulin, to alanine mutants of the ligand binding determinants of these subdomains. cDNAs encoding mutant secreted recombinant receptors were transiently expressed in 293 EBNA cells, and the binding properties for this analog of the expressed receptors were evaluated. In general des-(B25-30)-[His-A8, Asp-B10, Tyr-B25 alpha-carboxamide]insulin binding correlated with insulin binding, suggesting that both peptides bound to the receptor in a similar manner. Alanine mutations of eight amino acids (Asn15, Phe64, Phe705, Glu706, Tyr708, Leu709, Asn711, and Phe714) of the receptor produced the most profound decreases in affinity for des-(B25-30)-[His-A8, Asp-B10, Tyr-B25 alpha-carboxamide]insulin, suggesting that interactions with these amino acids contributed the major part of the free energy of the ligand-receptor interaction. Mutation of Arg14 and His710 to Ala produced receptors with undetectable insulin binding but an affinity for des-(B25-30)-[His-A8, Asp-B10, Tyr-B25 alpha-carboxamide]insulin only 8-23-fold less than for native receptor. Further analog studies were performed to elucidate this paradox. The receptor binding potencies of His-A8 and Asp-B10 insulins for these receptor mutants appeared to parallel their relative potencies for native receptor. In contrast the receptor binding potency of des-(B25-30)-[Tyr-B25 alpha-carboxamide]insulin was disproportionately increased for these mutants when compared with its potency for native receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999905     DOI: 10.1074/jbc.272.4.2077

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists.

Authors:  Brian J Smith; Kun Huang; Geoffrey Kong; Shu Jin Chan; Satoe Nakagawa; John G Menting; Shi-Quan Hu; Jonathan Whittaker; Donald F Steiner; Panayotis G Katsoyannis; Colin W Ward; Michael A Weiss; Michael C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-26       Impact factor: 11.205

2.  Structural determinants of the insulin receptor-related receptor activation by alkali.

Authors:  Igor E Deyev; Alla V Mitrofanova; Egor S Zhevlenev; Nikita Radionov; Anastasiya A Berchatova; Nadezhda V Popova; Oxana V Serova; Alexander G Petrenko
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Authors:  Meizhen Lou; Thomas P J Garrett; Neil M McKern; Peter A Hoyne; V Chandana Epa; John D Bentley; George O Lovrecz; Leah J Cosgrove; Maurice J Frenkel; Colin W Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

4.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

Review 5.  Theoretical and computational studies of peptides and receptors of the insulin family.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2015-02-11

6.  Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses.

Authors:  Kateřina Macháčková; Květoslava Mlčochová; Pavlo Potalitsyn; Kateřina Hanková; Ondřej Socha; Miloš Buděšínský; Anja Muždalo; Martin Lepšík; Michaela Černeková; Jelena Radosavljević; Milan Fábry; Katarína Mitrová; Martina Chrudinová; Jingjing Lin; Yevgen Yurenko; Pavel Hobza; Irena Selicharová; Lenka Žáková; Jiří Jiráček
Journal:  J Biol Chem       Date:  2019-09-26       Impact factor: 5.157

7.  A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information.

Authors:  Miguel E Rentería; Neha S Gandhi; Pablo Vinuesa; Erik Helmerhorst; Ricardo L Mancera
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

8.  Flexibility in the insulin receptor ectodomain enables docking of insulin in crystallographic conformation observed in a hormone-bound microreceptor.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2014-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.